Shares of Veeva Systems Inc. (NYSE:VEEV – Get Free Report) gapped up before the market opened on Thursday after Scotiabank raised their price target on the stock from $240.00 to $245.00. The stock had previously closed at $219.94, but opened at $232.84. Scotiabank currently has a sector perform rating on the stock. Veeva Systems shares last traded at $237.12, with a volume of 627,134 shares.
A number of other analysts have also commented on VEEV. Royal Bank of Canada lifted their target price on shares of Veeva Systems from $275.00 to $285.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Evercore ISI lifted their price objective on Veeva Systems from $220.00 to $245.00 and gave the stock an “in-line” rating in a research note on Friday, December 6th. Robert W. Baird upped their price objective on Veeva Systems from $283.00 to $285.00 and gave the company an “outperform” rating in a report on Thursday. JPMorgan Chase & Co. raised their target price on Veeva Systems from $208.00 to $218.00 and gave the stock a “neutral” rating in a report on Monday, December 16th. Finally, Canaccord Genuity Group upped their price target on Veeva Systems from $210.00 to $270.00 and gave the company a “hold” rating in a research note on Friday, December 6th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $255.28.
Check Out Our Latest Analysis on Veeva Systems
Hedge Funds Weigh In On Veeva Systems
Veeva Systems Price Performance
The firm has a 50-day moving average of $224.25 and a 200 day moving average of $219.66. The stock has a market capitalization of $38.39 billion, a price-to-earnings ratio of 58.39, a PEG ratio of 1.89 and a beta of 0.85.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
See Also
- Five stocks we like better than Veeva Systems
- The 3 Best Retail Stocks to Shop for in August
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- Canada Bond Market Holiday: How to Invest and Trade
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- Why Are These Companies Considered Blue Chips?
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.